Literature DB >> 28084336

Giant cell tumor of soft tissue is genetically distinct from its bone counterpart.

Jen-Chieh Lee1, Cher-Wei Liang1, Christopher Dm Fletcher2.   

Abstract

Giant cell tumors of bone are locally aggressive bone neoplasms with a predilection for young adults. Histologically, they are composed of histiocytoid to spindled mononuclear cells, admixed with numerous large osteoclastic giant cells. Giant cell tumors of soft tissue are rare tumors that bear striking histological resemblance to giant cell tumors of bone and might be regarded as a soft tissue analog thereof. Point mutations of the H3F3A gene (coding for a histone H3.3 protein) at the Gly34 codon, mostly G34W resulting from a GGG>TGG nucleotide change, have recently been identified in a vast majority of giant cell tumors of bone. To delineate the possible pathogenic linkage between both tumor types, we analyzed the H3F3A genotypes in a series of 15 giant cell tumors of soft tissue by Sanger sequencing and found no mutation in any case. We then sequenced cognate histone H3 genes with an identical nucleotide sequence ('GGG') at the codon Gly34, including the H3F3B, H3F3C, HIST2H3A, HIST2H3C, and HIST2H3D genes, and no somatic mutation was detected. These results reveal that giant cell tumors of soft tissue are probably genetically distinct from their bone counterparts and suggest that they might be pathogenically unrelated. Given the prominence of non-neoplastic cells in these tumors and the limitations of the current study, however, analyses using more sensitive techniques might be required to solve the issue.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28084336     DOI: 10.1038/modpathol.2016.236

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

1.  Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.

Authors:  Yu Sin Lau; Afsaneh Sabokbar; C L M H Gibbons; Henk Giele; Nicholas Athanasou
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

Review 2.  Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature.

Authors:  J A Bridge; J R Neff; B J Mouron
Journal:  Cancer Genet Cytogenet       Date:  1992-01

3.  Telomeric association in women with breast and uterine cervix cancer.

Authors:  C Paz-y-Miño; M E Sánchez; M Del Pozo; M A Baldeón; A Córdova; S Gutiérrez; M S Peñaherrera; M Neira; L Ocampo; P E Leone
Journal:  Cancer Genet Cytogenet       Date:  1997-10-15

4.  Primary giant cell tumor of soft tissues: a study of 22 cases.

Authors:  A M Oliveira; A P Dei Tos; C D Fletcher; A G Nascimento
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

5.  Giant-cell tumours of soft tissues.

Authors:  R Salm; H A Sissons
Journal:  J Pathol       Date:  1972-05       Impact factor: 7.996

6.  The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.

Authors:  Carolina Cavaliéri Gomes; Marina Gonçalves Diniz; Fabrício Rezende Amaral; Bruna Viana Antonini Guimarães; Ricardo Santiago Gomez
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-08-01

Review 7.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

8.  Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.

Authors:  Alyaa Al-Ibraheemi; Carrie Y Inwards; Riyam T Zreik; Doris E Wenger; Sarah M Jenkins; Jodi M Carter; Jennifer M Boland; Peter S Rose; Long Jin; Andre M Oliveira; Karen J Fritchie
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

9.  Telomeric association of chromosomes in B-cell lymphoid leukemia.

Authors:  P H Fitzgerald; C M Morris
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Authors:  Sam Behjati; Patrick S Tarpey; Nadège Presneau; Susanne Scheipl; Nischalan Pillay; Peter Van Loo; David C Wedge; Susanna L Cooke; Gunes Gundem; Helen Davies; Serena Nik-Zainal; Sancha Martin; Stuart McLaren; Victoria Goodie; Ben Robinson; Adam Butler; Jon W Teague; Dina Halai; Bhavisha Khatri; Ola Myklebost; Daniel Baumhoer; Gernot Jundt; Rifat Hamoudi; Roberto Tirabosco; M Fernanda Amary; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Adrienne M Flanagan
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more
  7 in total

Review 1.  What is new about the molecular genetics in matrix-producing soft tissue tumors? -The contributions to pathogenetic understanding and diagnostic classification.

Authors:  Yu-Chien Kao; Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

2.  Evaluation of giant cell tumors by diffusion weighted imaging-fractional ADC analysis.

Authors:  Oganes Ashikyan; M Chalian; D Moore; Y Xi; P Pezeshk; A Chhabra
Journal:  Skeletal Radiol       Date:  2019-04-19       Impact factor: 2.199

3.  Case Report: Giant Cell Tumor of Tendon Sheath After Breast Augmentation.

Authors:  Yu Zhang; Yingying Fan; Hongying Zhang; Hong Bu; Min Chen; Jieliang Yang; Zhang Zhang
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

4.  Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.

Authors:  Emanuela Palmerini; Laura Pazzaglia; Luca Cevolani; Loredana Pratelli; Michela Pierini; Irene Quattrini; Elisa Carretta; Maria Cristina Manara; Michela Pasello; Giorgio Frega; Anna Paioli; Alessandra Longhi; Marilena Cesari; Rossella Hakim; Toni Ibrahim; Laura Campanacci; Eric Lodewijk Staals; Davide Maria Donati; Maria Serena Benassi; Katia Scotlandi; Stefano Ferrari
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

5.  Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors.

Authors:  Andrew L Folpe; Kemal Kösemehmetoğlu; Abbas Agaimy; Michael Michal; Robert Stoehr; Fulvia Ferrazzi; Pavel Fabian; Michal Michal; Alessandro Franchi; Florian Haller
Journal:  Mod Pathol       Date:  2021-03-19       Impact factor: 7.842

6.  First Case Report of a Huge Giant Cell Tumor of Soft Tissue Originating from the Retroperitoneum.

Authors:  Shinji Kishi; Hiroyuki Monma; Hiroshige Hori; Shoichi Kinugasa; Masayo Fujimoto; Takeshi Nakamura
Journal:  Am J Case Rep       Date:  2018-06-05

7.  Edgetic perturbation signatures represent known and novel cancer biomarkers.

Authors:  Evans Kataka; Jan Zaucha; Goar Frishman; Andreas Ruepp; Dmitrij Frishman
Journal:  Sci Rep       Date:  2020-03-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.